For the year ending 2025-12-31, AUPH made $283,055K in revenue. $287,250K in net income. Net profit margin of 101.48%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenue | 283,055 | 235,133 | ||
| Cost of revenue | 32,665 | 28,248 | ||
| Selling, general and administrative | 101,794 | 172,028 | ||
| Research and development | 32,505 | 20,785 | ||
| Restructuring | 1,647 | 23,106 | ||
| Other expense (income), net | -9,530 | 4,347 | ||
| Total operating expenses | 178,141 | 239,820 | ||
| Income (loss) from operations | 104,914 | -4,687 | ||
| Interest income | 13,573 | 16,970 | ||
| Interest expense | 4,330 | 4,835 | ||
| Net income (loss) before income taxes | 114,157 | 7,448 | ||
| Income tax (benefit) expense | -173,045 | 1,696 | ||
| Net income (loss) | 287,202 | 5,752 | ||
| Unrealized gain on available-for-sale securities | 48 | 83 | ||
| Comprehensive income (loss) | 287,250 | 5,835 | ||
| Basic EPS | 2.14 | 0.04 | ||
| Diluted EPS | 2.07 | 0.04 | ||
| Basic Average Shares | 134,367,000 | 143,057,000 | ||
| Diluted Average Shares | 138,700,000 | 146,194,000 | ||
Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. (AUPH)